COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

被引:0
|
作者
Joshua Elliott
Barbara Bodinier
Matthew Whitaker
Cyrille Delpierre
Roel Vermeulen
Ioanna Tzoulaki
Paul Elliott
Marc Chadeau-Hyam
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, School of Public Health
[2] St Mary’s Hospital,MRC Centre for Environment and Health
[3] Norfolk Place,UMR LEASP
[4] Imperial College,Department of Hygiene and Epidemiology
[5] Royal Surrey County Hospital,Institute for Risk Assessment Sciences (IRAS)
[6] Université de Toulouse III,undefined
[7] UPS,undefined
[8] Inserm,undefined
[9] University of Ioannina Medical School,undefined
[10] Utrecht University,undefined
来源
关键词
COVID-19 mortality; SARS-CoV-2; Prospective cohort; UK biobank; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10–17), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10–6) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10–7) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [21] Risk Factors for COVID-19 Mortality
    Noitz, Matthias
    Meier, Jens
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2023, 58 (06): : 362 - 372
  • [22] Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
    Jianchang Hu
    Cai Li
    Shiying Wang
    Ting Li
    Heping Zhang
    Human Genomics, 15
  • [23] Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
    Hu, Jianchang
    Li, Cai
    Wang, Shiying
    Li, Ting
    Zhang, Heping
    HUMAN GENOMICS, 2021, 15 (01)
  • [24] Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants
    Mutambudzi, Miriam
    Niedwiedz, Claire
    Macdonald, Ewan Beaton
    Leyland, Alastair
    Mair, Frances
    Anderson, Jana
    Celis-Morales, Carlos
    Cleland, John
    Forbes, John
    Gill, Jason
    Hastie, Claire
    Ho, Frederick
    Jani, Bhautesh
    Mackay, Daniel F.
    Nicholl, Barbara
    O'Donnell, Catherine
    Sattar, Naveed
    Welsh, Paul
    Pell, Jill P.
    Katikireddi, Srinivasa Vittal
    Demou, Evangelia
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 78 (05) : 307 - 314
  • [25] Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort
    Lehrer, Steven
    Rheinstein, Peter H.
    IN VIVO, 2021, 35 (02): : 965 - 968
  • [26] Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study
    Ho, Frederick K.
    Celis-Morales, Carlos A.
    Gray, Stuart R.
    Katikireddi, S. Vittal
    Niedzwiedz, Claire L.
    Hastie, Claire
    Ferguson, Lyn D.
    Berry, Colin
    Mackay, Daniel F.
    Gill, Jason M. R.
    Pell, Jill P.
    Sattar, Naveed
    Welsh, Paul
    BMJ OPEN, 2020, 10 (11):
  • [27] Risk Factors for COVID-19 Mortality in Malaysia
    Hanis, Tengku Muhammad
    Arifin, Wan Nor
    Musa, Kamarul Imran
    Hasani, Wan Shakira Rodzlan
    Nawi, Che Muhammad Nur Hidayat Che
    Shahrani, Shahnon Anuar
    Chen, Xin Wee
    Suliman, Mohd Azmi
    Khan, Erwan Ershad Ahmad
    Aziz, Wira Alfatah Ab
    Said, Mohamad Zarudin Mat
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (06): : 123 - 131
  • [28] Is Cohort Representativeness Passe? Poststratified Associations of Lifestyle Risk Factors with Mortality in the UK Biobank
    Stamatakis, Emmanuel
    Owen, Katherine B.
    Shepherd, Leah
    Drayton, Bradley
    Hamer, Mark
    Bauman, Adrian E.
    EPIDEMIOLOGY, 2021, 32 (02) : 179 - 188
  • [29] COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank
    Can Hou
    Yihan Hu
    Huazhen Yang
    Wenwen Chen
    Yu Zeng
    Zhiye Ying
    Yao Hu
    Yajing Sun
    Yuanyuan Qu
    Magnús Gottfreðsson
    Unnur A. Valdimarsdóttir
    Huan Song
    BMC Medicine, 19
  • [30] COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank
    Hou, Can
    Hu, Yihan
    Yang, Huazhen
    Chen, Wenwen
    Zeng, Yu
    Ying, Zhiye
    Hu, Yao
    Sun, Yajing
    Qu, Yuanyuan
    Gottfredsson, Magnus
    Valdimarsdottir, Unnur A.
    Song, Huan
    BMC MEDICINE, 2021, 19 (01)